As part of their work for North Thames Research and Development, the King's Fund collected data on all Betaferon users from December 1995 to September 1996 in the North Thames region. They also organised discussion groups with 24 potential or actual users of the drug. The report looks at who ...
In the spring of 1996, the Implementation Group of North Thames Research and Development allocated £50000 to each of thirteen health authorities for evidence into practice implementation projects. In autumn 1996, the King's Fund Management College was commissioned to evaluate the 17 approved projects. In particular, they were interested in ...
In the spring of 1996, the Implementation Group of North Thames Research and Development allocated £50000 to each of thirteen health authorities for evidence into practice implementation projects. In autumn 1996, the King's Fund Management College was commissioned to evaluate the 17 approved projects. In particular, they were interested in ...
This project followed the introduction of beta-interferon in one health region. It provided the opportunity to pilot many helpful approaches to the active management of drugs in health authorities. The report concludes that many of the approaches used in this situation were successful and could be applied to future similar ...
This report addresses two questions: which factors influence people with relapsing remitting MS to come forward for new drug therapies?, and what do these group of people with MS want from an organisation such as the Multiple Sclerosis Society (MSS)? In addressing the first question, the authors discuss various discouraging ...